New York, USA, and Berlin, Germany – March 30, 2021
Rockefeller University Press has selected Morressier as its virtual conference provider for the Journal of Cell Biology (JCB) and Journal of Experimental Medicine (JEM) Symposium on Neurodegeneration. The symposium will bring together prominent and diverse researchers on April 26–27, 2021, for talks and poster presentations covering the latest advances in fundamental and translational research on Alzheimer’s disease, Parkinson’s disease, frontotemporal dementia, amyotrophic lateral sclerosis, and other neurodegenerative disorders.
“Neurodegenerative Diseases: Emerging mechanisms and Therapeutic opportunities,” will feature live-streamed presentations, networking, and a virtual poster hall. The Morressier platform also allows content to be hosted and searchable in an online library after the event, increasing its impact.
“Because so many meetings have switched to a virtual format over the past year, attendee expectations of the online experience have evolved,” says JCB Senior Scientific Editor Melina Casadio, a co-organizer of the neurodegeneration symposium. “We felt that Morressier’s interactive platform and its track record of working with scientific societies and institutions would enable us to provide the best virtual event. We look forward to engaging with attendees on the platform.”
Justus Weweler, Morressier Co-Founder and Director of Key Accounts, said: “Conferences play an essential role in the scientific process and the pivot to a virtual format provides a whole new way of discussing and exchanging conference content. We’re delighted to work with Rockefeller University Press to unlock the full value of the upcoming virtual JCB and JEM Symposium on Neurodegeneration. Together, we will ensure attendees have the tools they need to connect with their peers, share their critical findings, and make progress with their research."
Registration is free for “Neurodegenerative Diseases: Emerging mechanisms and Therapeutic opportunities,” and the program and list of speakers is available here.
About Rockefeller University Press (RUP)
Rockefeller University Press (RUP) is committed to quality and integrity in scientific publishing. RUP publishes Journal of Cell Biology (JCB), Journal of Experimental Medicine (JEM), and Journal of General Physiology (JGP) and co-publishes Life Science Alliance (LSA). RUP’s nonprofit journals were established by the research community, and editorial decisions and policies continue to be driven by scientists who actively contribute to their fields, appreciate the value of peer review, and desire a better publication experience for all. Based in New York City, RUP is a department of The Rockefeller University, a leading biomedical research university dedicated to conducting innovative, high-quality research to improve the understanding of life for the benefit of humanity.
Morressier is the leading platform for conferences designed for enduring value. Since 2014, more than 200 of the world’s leading professional and scientific organizations trust Morressier to support their virtual and hybrid meetings, engage their users, and amplify their content. Morressier offers its clients a powerful platform, granular data and analytics, and extensive possibilities for revenue generation. At the same time, by increasing access to previously ephemeral content, Morressier helps accelerate breakthroughs and innovation.